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Abstract: 
Introduction: Several molecular markers have been studied for their usefulness as 
prognostic markers in oral squamous cell carcinoma (OSCC). One such molecular 
marker is cyclin D1 which is a proto-oncogene located on 11q13 in humans. Objective: 
To explore the feasibility of using cyclin D1 as a prognostic marker in tongue and cheek 
SCC by the fluorescent-in-situ hybridization (FISH) method. Methods: Fifty paraffin-
embedded samples (25 each of cheek and tongue SCCs) were obtained from the 
archives of the Oral Pathology Diagnostic Laboratory. Sociodemographic data, 
histopathologic diagnoses, lymph node status and survival data were obtained from the 
Malaysian Oral Cancer Database and Tissue Bank System (MOCDTBS)coordinated by 
the Oral Cancer Research and Coordinating Centre (OCRCC), University of Malaya. 
The FISH technique was used to detect the amplification of cyclin D1 using the Vysis 
protocol. Statistical correlations of cyclin D1 with site and lymph node status were 
analyzed using the Fisher exact test. Kaplan-Meier and Log Rank (Mantel-Cox) test 
were used to analyze cyclin D1 amplification and median survival time. Results: Positive 
amplification of cyclin D1 was detected in 72% (36) of OSCCs. Detection of positive 
amplification for cyclin D1 was observed in 88% (22) and 56% (14) of the tongue and 
cheek tumors, respectively, where the difference was statistically significant (P=0.012). 
Lymph node metastasis of cheek SCCs showed a trend towards a significant 
association (P= 0.098) with cyclin D1 amplification whereas the lymph node metastasis 
of tongue SCC was clearly not significant (P=0.593).There was a statistically significant 
correlation between cyclin D1 positivity and survival rate (P=0.009) for overall SCC 
cases and (P<0.001) for cheek SCC cases. Conclusion: The present study found that 
cyclin D1 amplification may differ in different subsites of OSCC (tongue vs cheek) and 
its positive amplification implies an overall poor survival in OSCCs, particularly those 
arising in cheeks. 
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